5.71 USD
↘ 0.31 (5.15%)AT CLOSE (03:59 PM EST)
Palatin Technologies, Inc. Common Stock
PTNNASDAQ • USD
5.68
↘ 0.03 (0.60%)
POST MARKET (AS OF 06:41 PM EST)
Post Market
AS OF 06:41 PM EST
5.68
↘ 0.03 (0.60%)
Market: CLOSED
Palatin Technologies, Inc. Common Stock (PTN) trades at $5.60 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, PTN appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 5, 2026.
Open?$6.02
High?$6.04
Low?$4.76
Prev. Close?$6.02
Volume?57.3K
Avg. Volume?32.1K
VWAP?$5.64
Rel. Volume?1.78x
Bid / Ask
Bid?$4.58 × 100
Ask?$6.97 × 100
Spread?$2.39
Midpoint?$5.78
Valuation & Ratios
Market Cap?10.7M
Shares Out?1.8M
Float?1.7M
Float %?95.1%
P/E Ratio?N/A
P/B Ratio?1.60
EPS?-$4.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
Address
4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Phone: 609-495-2200
CRANBURY, NJ 08512
Phone: 609-495-2200
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?44
Piotroski F-Score?0/9Weak
Altman Z-Score?-74.18Distress
Confidence?54%Low
Short InterestVery High
Short % of Float?19.62%High
Short Interest?332.2K
Days to Cover?14.3
Free Float1.7M
Avg Daily Volume23.3K
Settlement Date2026-10-15
Financial Health
Current Ratio?4.61Strong
Quick Ratio?4.61Strong
Cash Ratio?4.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.60CHEAP▾
Peers100
S&P85
P/S?0.81CHEAP▾
Peers100
S&P90
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?0.24CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-125.3%WEAK▾
S&P3
ROA?-98.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-13584569
Enterprise Value?$3.2M
Fundamentals ratios updated end of day